Engrail Therapeutics
VerifiedAcquiring, developing and commercializing transformative medicines.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$628—942m (Dealroom.co estimates Mar 2024.)
San Diego California (HQ)
Deals in current and previous year:
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor | $0.0 | round | |
| investor investor | $0.0 | round | |
* | $157m | Series B | |
| Total Funding | 000k | ||
Related Content
Recent News about Engrail Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Engrail Therapeutics
Edit
ACQUISITION by Engrail Therapeutics Feb 2021